Jilin University Second Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Psoriasis2 trials
• Asthma1 trial
• Heart failure1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed3 trials
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Huabo Biopharm Co., Ltd.2 trials
• Beijing Hospital1 trial
• Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 trial
• Zensun Sci. & Tech. Co., Ltd.1 trial

Running trials

• Recruiting

  TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

  NCT06829784· Phase 3· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Source

  Contact: Ke Wang, Doctor

• Recruiting

  Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

  NCT03987308· Beijing Hospital· Source

  Contact: Hanqing Cai, M.D.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Phase 2 Study of HB0017 in Psoriasis Patients

  NCT06592274· Phase 2· Huabo Biopharm Co., Ltd.· Source

• Completed

  Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06477237· Phase 3· Huabo Biopharm Co., Ltd.· Source

• Completed

  Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

  NCT05949801· Phase 3· Zensun Sci. & Tech. Co., Ltd.· Source